VNDA
Vanda Pharmaceuticals Inc
5.00$
-1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -191.5% | – | – | – | – | – | – | – | – | – | |
| – | +99.7% | +92.1% | -11.5% | -0.1% | +0.3% | +0.5% | -240.5% | – | +185.6% | -39.8% | +105.0% | – | |
| – | +3.3% | +9.5% | -16.7% | +0.4% | -4.5% | +3.8% | -29.1% | +0.3% | +8.2% | +12.2% | +82.2% | – | |
| – | – | +147.4% | -166.1% | – | – | -366.6% | – | -153.0% | – | -360.6% | – | – | |
| – | +954.2% | -97.2% | +1,442.9% | +49.1% | +32.9% | +103.7% | -31.4% | -46.2% | -36.6% | +116.7% | +86.0% | – | |
| – | -223.9% | -58.4% | -16.2% | – | -66.9% | +999.5% | -134.8% | – | +110.0% | -54.9% | +167.1% | – | |
| – | – | – | – | – | – | – | +3.9% | +21.6% | +23.8% | +21.2% | +10.3% | – | |
| – | – | – | – | – | – | +754.2% | -67.9% | +21.6% | +23.8% | +21.2% | +110.3% | – | |
| – | -242.9% | – | – | – | – | +421.2% | -425.0% | – | – | -307.1% | – | – | |
| – | – | – | -193.0% | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.